Search alternatives:
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 61 - 80 results of 99,493 for search '(( 2000 step decrease ) OR ( 5 ((teer decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.61s Refine Results
  1. 61
    sC5b-9 patients decrease in patients treated with mycophenolate mofetil.

    sC5b-9 patients decrease in patients treated with mycophenolate mofetil. by Joshua M. Thurman (517193)

    Published 2015
    “…When analyzed separately based upon treatment, the decrease in sC5b-9 levels was due to a decrease in patients treated with mycophenolate mofetil (P < 0.001 by linear regression; n = 12 for all time-points). …”
    Save to List
    Saved in:
  2. 62
    Responding Vγ9Vδ2-individuals decreases among HIV-infected patients who present lower Vγ9Vδ2 T-cell number than HD.

    Responding Vγ9Vδ2-individuals decreases among HIV-infected patients who present lower Vγ9Vδ2 T-cell number than HD. by Rita Casetti (608635)

    Published 2015
    Save to List
    Saved in:
  3. 63
    Dose- and time-dependent effect of IFN-γ and TNF-α on benzamil-sensitive <i>I</i><sub>sc</sub> and TEER in HBECs.

    Dose- and time-dependent effect of IFN-γ and TNF-α on benzamil-sensitive <i>I</i><sub>sc</sub> and TEER in HBECs. by Anusree Sasidharan (19226521)

    Published 2024
    Save to List
    Saved in:
  4. 64
    A647D decreased mexiletine sensitivity of P1332L when coexpressed.

    A647D decreased mexiletine sensitivity of P1332L when coexpressed. by Jie Liu (15128)

    Published 2018
    Save to List
    Saved in:
  5. 65
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  6. 66
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  7. 67
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  8. 68
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  9. 69
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  10. 70
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  11. 71
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  12. 72
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  13. 73
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  14. 74
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  15. 75
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  16. 76
    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity

    Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

    Published 2014
    Subjects:
    Save to List
    Saved in:
  17. 77
    MMP-2 production is decreased following ALK5 inhibition.

    MMP-2 production is decreased following ALK5 inhibition. by Rebecca A. Scott (488956)

    Published 2020
    Save to List
    Saved in:
  18. 78
    PDGF-BB-induced NR4A1 expression is decreased after treatment with the NF-κB inhibitor BAY11-7082.

    PDGF-BB-induced NR4A1 expression is decreased after treatment with the NF-κB inhibitor BAY11-7082. by Glenda Eger (636934)

    Published 2014
    Save to List
    Saved in:
  19. 79
    L665W decreased AR5A binding to H77/JFH1 particles and to the E1/E2 complex in H77/JFH1 infected cells, but did not alter receptor dependency.

    L665W decreased AR5A binding to H77/JFH1 particles and to the E1/E2 complex in H77/JFH1 infected cells, but did not alter receptor dependency. by Rodrigo Velázquez-Moctezuma (3776023)

    Published 2017
    Save to List
    Saved in:
  20. 80
    A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity

    A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity by Regina Michelis (2889092)

    Published 2019
    “…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”
    Save to List
    Saved in:

Search Tools: